Cafepharma | Pharmaceutical Sales, Medical Sales, Lab Sales

Cafepharma Today

November 29 2023 - FDA names chief scientist Bumpus as Woodcock’s successor

FDA names chief scientist Bumpus as Woodcock’s successor
FDA launches probe of malignancies linked to CAR-T therapies
FDA kicks off review of Karuna’s schizophrenia drug KarXT
Lilly puts potential $660M on the line for protein-protein interaction blockers
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Manufacturer Lonza says it will not fill obesity drug syringes

Reuters

Friday, November 17, 2023 - 10:02am

tags:

Lonza, drug manufacturing, obesity, Novo Nordisk, Eli Lilly

AbbVie’s Migraine Drug Ubrelvy Scores Victory in Phase III Study

BioSpace

Friday, November 17, 2023 - 10:00am

tags:

AbbVie, Ubrelvy, ubrogepant, migraines, clinical trials

Johnson & Johnson Is Eyeing Intuitive Surgical's Market, But Can It Win?

Motley Fool

Friday, November 17, 2023 - 9:59am

tags:

JNJ, Intuitive Surgical, Medtech, robotic surgery

Japan to buy 1.4 mln doses of Daiichi Sankyo COVID vaccine

Reuters

Thursday, November 16, 2023 - 10:22pm

tags:

Japan, Daiichi Sankyo, COVID-19, vaccines

Top FDA official Woodcock to retire early next year

BioPharma Dive

Thursday, November 16, 2023 - 10:20pm

tags:

FDA, Janet Woodcock

Astellas pays $175M for Propella, clearing early-phase rival to J&J's Zytiga for takeoff

Fierce Biotech

Thursday, November 16, 2023 - 11:45am

tags:

Astellas, Propella Therapeutics, M&A, JNJ, Zytiga, prostate cancer

Valneva single-dose chikungunya vaccine poised to ‘revolutionize’ global health

Biopharma Reporter

Thursday, November 16, 2023 - 11:38am

tags:

Valneva, vaccines, Ixchiq, FDA, chikungunya virus

Astellas Sees Path Forward for Gene Therapy Despite Four Patient Deaths

BioSpace

Thursday, November 16, 2023 - 11:36am

tags:

Astellas, AT132, patient deaths, FDA, X-linked myotubular myopathy

FDA skeptical of Merck’s gefapixant, even after cough recount

Fierce Biotech

Thursday, November 16, 2023 - 11:34am

tags:

Merck, chronic cough, gefapixant

Vertex, CRISPR Win World’s First Approval for CRISPR-Edited Therapy from UK

BioSpace

Thursday, November 16, 2023 - 10:21am

tags:

CRISPR, gene editing, Vertex Pharmaceuticals, CRISPR Therapeutics, UK, Casgevy, beta thalassemia

PostEra Announces a Research Collaboration with Amgen to Discover Small Molecule Therapeutics using Artificial Intelligence

PR Newswire

Thursday, November 16, 2023 - 10:18am

tags:

Amgen, PostEra, artificial intelligence, drug discovery

Vicarious delays surgical robot as integration challenges, R&D cuts slow development

Medtech Dive

Thursday, November 16, 2023 - 10:17am

tags:

Medtech, Vicarious Surgical, robotic surgery

LENZ Therapeutics and Graphite Bio agree to merge

Pharmaceutical Technology

Thursday, November 16, 2023 - 10:15am

tags:

Graphite Bio, Lenz Therapeutics, M&A, presbyopia

Certa plans pivotal scleroderma trial after Phase II data readout

Clinical Trials Arena

Thursday, November 16, 2023 - 10:13am

tags:

Certa, scleroderma, clinical trials, FT011

BMS gets US approval for ROS1 lung cancer drug Augtyro

Pharmaphorum

Thursday, November 16, 2023 - 10:11am

tags:

Bristol Myers Squibb, Augtyro, Turning Point Therapeutics, lung cancer, FDA

Biden administration’s limit on drug industry middlemen backfires, pharmacists say

Medical Marketing and Media

Thursday, November 16, 2023 - 10:10am

tags:

PBMs, Joe Biden

Cigna's Express Scripts launches cost-based drug pricing model

Investing.com

Thursday, November 16, 2023 - 10:06am

tags:

PBMs, Cigna, Express Scripts, drug pricing, cost-based pricing

A year after Roche's Alzheimer's failure, scientists reflect on what could have been

Fierce Biotech

Wednesday, November 15, 2023 - 11:49pm

tags:

Roche, Genentech, Alzheimer's disease, gantenerumab

Why Eli Lilly Stock Flopped While the Market Popped Today

Motley Fool

Wednesday, November 15, 2023 - 11:47pm

tags:

Eli Lilly, Europe, drug manufacturing

Mallinckrodt emerges from bankruptcy

Beckers Hospital Review

Wednesday, November 15, 2023 - 11:44pm

tags:

Mallinckrodt, bankruptcy

Pages

Latest CP Wire Articles

First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study

Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth

Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Sapio Sciences launches new drug discovery platform

Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics

Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business

Bend Bioscience Adds Capacity and Technology Offerings with the Addition of New Process and Manufacturing Science Facility

Eastman introduces new excipient to formulate poorly soluble API

Most-clicked pharma news for week ending April 1 2023: Signify Health acquisition, Ferring Research Institute shutdown, Jardiance sales increase, and more

PharmaBlock Receives 2023 ACS CMO Excellence in Green Chemistry Award

Latest Pharmagather Articles

Drug Channels News Roundup, November 2023: My $0.02 on Express Scripts’ Cost-Based Pricing, Mark Cuban vs. PBMs, Dual-WAC Strategies, Pharmacy Shakeout, and Adam vs. Rocky

Drug Channels

Simplify and Accelerate Benefits Verification with a Fully Integrated, Adaptable Platform

Drug Channels

Medicare Part D in 2024: Mapping Large Chains' Position in 2024’s Preferred Pharmacy Networks

Drug Channels

Drug Channels Outlook 2024 (NEW Live Video Webinar)

Drug Channels

Four Trends That Are Shaping the Future of Market Access

Drug Channels

FDA’s OPDP Issues Two New Untitled Letters

eye on fda

Vertical Integration Lessons: The Economics and Strategies of Hospital-Owned Specialty Pharmacies

Drug Channels

Is Your Hub Partner Missing the Therapeutic Area Expertise You Need?

Drug Channels

Drug Channels News Roundup, October 2023: CVS & Humira Biosimilars, GLP-1 G2N Bubble, 340B Abuses, Rite Aid's Endgame, Mark Cuban Update, and an Epic Meetup

Drug Channels